Haleon (HLN) Cash from Discontinued Operations (2021 - 2023)

Haleon (HLN) posted Cash from Discontinued Operations of 929622762.15 for Q4 2023, up 16.55% on a QoQ basis from 797591258.37 in Q4 2022, and up 16.55% year-over-year from 797591258.37 in Q4 2022.

Haleon (HLN) Cash from Discontinued Operations (2021 - 2023) Analysis & Trends

Haleon's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 929622762.15 for Q4 2023.

  • Quarterly Cash from Discontinued Operations rose 16.55% year-over-year to 929622762.15 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2879929120.14 (changed N/A YoY) and the FY2024 annual result came in at 2941311634.91, up 12.61% from the prior year.
  • Cash from Discontinued Operations was 929622762.15 for Q4 2023 at Haleon, up from 797591258.37 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 929622762.15 in Q4 2023 and bottomed at 315434482.08 in Q4 2021.
  • A 3-year average of 719982280.03 and a median of 817435937.95 in 2022 frame the typical range for Cash from Discontinued Operations.
  • Annual changes were most pronounced in 2022 — Cash from Discontinued Operations surged 152.85% — and 2023, when it gained 16.55%.
  • Haleon's Cash from Discontinued Operations stood at 315434482.08 in 2021, then jumped by 152.85% to 797591258.37 in 2022, then climbed by 16.55% to 929622762.15 in 2023.
  • Business Quant data shows HLN's Cash from Discontinued Operations at 929622762.15 in Q4 2023, 797591258.37 in Q4 2022, and 837280617.53 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 929.62 Mn
Dec 31, 2023 929.62 Mn
Dec 31, 2022 797.59 Mn
Dec 31, 2022 797.59 Mn
Sep 20, 2022 837.28 Mn
Sep 20, 2022 837.28 Mn
Dec 31, 2021 315.43 Mn
Dec 31, 2021 315.43 Mn